Reimagining therapeutic delivery

We’re innovating smart-pill technologies designed to deliver the right dose to the right place, safely.

BioJet™ Oral Therapeutic Delivery Platform

Needle-free, oral delivery of large molecules designed to replace injection for better management of chronic diseases.

Learn More

Press Releases

Publications

Single ascending dose results from a Phase 1 clinical trial of BT-600, a combination product of the NaviCap™ targeted oral delivery platform and tofacitinib

October 28, 2024 #NaviCap Targeted Therapeutic Delivery

Results of human device function studies for the NaviCap™ Targeted Oral Delivery Platform in healthy volunteers and patients with UC

May 18, 2024 #NaviCap Targeted Therapeutic Delivery

Evaluation of the pharmacokinetics of GLP-1 receptor agonist delivered through the BioJet™ oral biotherapeutic delivery platform in a porcine model: an update

October 4, 2023 #BioJet Oral Therapeutic Delivery